Table 3.
Anemia and its associated factors before ART initiation in HIV positive patients attending Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2017
| Variables | Anemic | Non anemic | X2 | P value | AOR (95% CI) |
|---|---|---|---|---|---|
| Age(in years) | |||||
| <30 | 13 (39.4%) | 20 (60.6%) | 0.10 | 0.95 | 1.13 (0.49–2.63) |
| 30–40 | 48 (42.5%) | 65 (57.5%) | 1.02 (0.58–1.78) | ||
| >40 | 46 (42.2%) | 63 (57.8%) | 1.00 | ||
| Sex | |||||
| Male | 47 (43.9%) | 60 (56.1%) | 0.21 | 0.65 | 1.09 (0.64–1.86) |
| Female | 60 (40.5%) | 88 (59.5%) | 1.00 | ||
| WHO clinical stages | |||||
| Stage I/II | 32 (32%) | 68 (68%) | 6.70 | 0.01 | 1.00 |
| Stage III/IV | 75 (48.4%) | 80 (51.6%) | 1.83 (1.06–3.15) | ||
| CD4 count (cells/mm3) | |||||
| <200 | 89 (49.4%) | 91 (50.6%) | 14.07 | < 0.001 | 2.91 (1.57–5.39) |
| ≥200 | 18 (24%) | 57 (76%) | 1.00 | ||
Numerical data in bold indicates the level of significance (p < 0.05), AOR Adjusted odds ratio, CI Confidence interval, 1.00 = reference group